PRDM1 and autoimmune disease: A spatiotemporally controllable Blimp-1–IL-21 autoregulatory loop recapitulates the dynamics of the RNA and protein landscape in precision medicine as an emerging approach to tailor optimal therapeutic interventions for improving outcomes among autoimmune disease patients with therapy resistance.